Home › DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac
 

Keywords :   


DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac

2014-10-01 11:13:37| Biotech - Topix.net

DanDrit Biotech A/S , the subsidiary of DanDrit Biotech USA, Inc. , a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST - National Institute for Cancer Research known as the San Martino Hospital of Genoa. Dr. Alberto Sobrero, the Head of the Medical Oncology Unit at the San Martino Hospital is principal investigator of the randomized multicenter study.

Tags: agreement signs clinical trials

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »